日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting sorting nexin 3 to treat pulmonary fibrosis by dual modulating Wnt/β-catenin signaling.

通过双重调节 Wnt/β-catenin 信号通路靶向分选连接蛋白 3 治疗肺纤维化。

Ma Dinghu, Yu Wenjing, Zhou Hang, Lin Rongyuan, Sun Ximeng, Peng Mingxia, Lin Chenjia, Du Haoyu, Li Yueqi, Liang Huimin, Sun Duanping, Liu Peiqing, Lu Jing

Using period analysis to timely provide serial data on long-term survival for liver cancer patients from China

利用时期分析法及时提供中国肝癌患者长期生存的系列数据。

Chen, Pengtao; Gu, Wei; Bing, Xin; Wang, Liangyou; Cheng, Yongran; Chen, Xukai; Zhang, Dinghu; Chen, Tianhui

Heat stress-induced heat shock protein 90 alpha family class A member 1 upregulation stabilizes yes-associated protein through ubiquitination inhibition to boost hepatic cancer radiofrequency hyperthermia resistance

热应激诱导的热休克蛋白90α家族A类成员1上调通过抑制泛素化稳定YES相关蛋白,从而增强肝癌射频热疗耐受性。

Bao, Zhehan; Jiang, Yi; Liang, WeiRen; Zhang, Dinghu; Guo, Liwen

GPLD1 Attenuates Heart Failure via Dual-Membrane Localization to Inhibit uPAR

GPLD1通过双膜定位抑制uPAR,从而减轻心力衰竭。

Yu, Wenjing; Guo, Zhen; Liang, Huimin; Ma, Dinghu; Lin, Chenjia; Li, Zeyu; Yu, Jiaying; Ataran, Anahita; Javaheri, Ali; Liu, Zhiping; Sun, Duanping; Liu, Peiqing; Lu, Jing

Improved Hypoxic Microenvironment By Nanoformulation For Effective T Cell Therapy In Mice Model

纳米制剂改善低氧微环境,促进小鼠模型中T细胞的有效治疗

Feng, Xiaoyu; Zhu, Hao; Shen, Jingwen; Wang, Yan; Liu, Shutong; Chen, Xinjie; Ke, Yaohua; Zhang, Dinghu; Yu, Lixia; Liu, Baorui; Liu, Qin; Wang, Hao; Chu, Yanhong

Multiple valence states of Fe boosting SERS activity of Fe(3)O(4) nanoparticles and enabling effective SERS-MRI bimodal cancer imaging

铁的多种价态增强了Fe(3)O(4)纳米粒子的表面增强拉曼散射(SERS)活性,并实现了有效的SERS-MRI双模态癌症成像。

Lin, Jie; Ma, Xuehua; Li, Anran; Akakuru, Ozioma Udochukwu; Pan, Chunshu; He, Meng; Yao, Chenyang; Ren, Wenzhi; Li, Yanying; Zhang, Dinghu; Cao, Yi; Chen, Tianxiang; Wu, Aiguo

A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy

一种基于分子特征评分的新型分子分型系统,能够识别对免疫疗法和靶向疗法敏感的患者。

Li, Yang; Ding, Yinan; Wang, Jinghao; Wu, Xiaoxia; Zhang, Dinghu; Zhou, Han; Zhang, Pengfei; Shao, Guoliang

Case Report: Diagnostic challenges in Fabry disease: misinterpreted obstructive hypertrophic cardiomyopathy and the role of enzyme replacement therapy

病例报告:法布里病诊断的挑战:误诊为梗阻性肥厚型心肌病及酶替代疗法的作用

Cheng, Weili; Ao, Mingqiang; Xu, Dinghu; Zhang, Yuqing; Tao, Qin

Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomized controlled trial

经动脉化疗栓塞术单药治疗与联合安罗替尼治疗中晚期肝细胞癌患者的疗效和安全性比较:一项II期随机对照试验

Zhang, Dinghu; Zhang, Zhewei; Luo, Jun; Zheng, Jiaping; Mao, Xiaochun; Tsilimigras, Diamantis I; Chun, Ho Jong; Zeng, Hui

Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis

对 nexin 3 进行分类可通过调节 TFRC 依赖性铁死亡加剧阿霉素诱发的心肌病

Wenjing Yu, Yuehuai Hu, Zhiping Liu, Kaiteng Guo, Dinghu Ma, Mingxia Peng, Yuemei Wang, Jing Zhang, Xiaolei Zhang, Panxia Wang, Jiguo Zhang, Peiqing Liu, Jing Lu